Biohaven Ltd

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$13.57

-0.05 (-0.37%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 76%

Hold 6 24%

Sell 0 0%

Price Target

Analyst Price Target +121.5% upside

Low Target $17.22

Average Target $30.06

High Target $35.82

Current Price $13.57

Current
$13.57

Target
$30.06

$17.22 $30.06 avg $35.82

Scenario Analysis

Bear Case

$17.22

26.9%

Low target

Base Case

$30.06

+121.5%

Avg target

Bull Case

$35.82

+164.0%

High target

Risk/Reward

6.1x

Highly favorable

Price in Context

52-Week High

$18.57

-26.9% from high

52-Week Low

$7.48

+81.4% from low

Target vs 52W High

$30.06

+61.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%